Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022434
Company: CIPLA
Company: CIPLA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ARGATROBAN IN SODIUM CHLORIDE | ARGATROBAN | 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/29/2011 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022434s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022434s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022434_argatroban_toc.html https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022434Orig1s000SumR.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 06/10/2026 | SUPPL-14 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022434s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/022434Orig1s014ltr.pdf | |
| 12/06/2019 | SUPPL-13 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022434s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022434Orig1s013ltr.pdf | |
| 06/18/2018 | SUPPL-11 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022434s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022434Orig1s011ltr.pdf | |
| 05/26/2016 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022434s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022434Orig1s010ltr.pdf | |
| 08/18/2015 | SUPPL-8 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 08/05/2015 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 09/09/2014 | SUPPL-6 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022434s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022434Orig1s006ltr.pdf | |
| 01/16/2014 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 06/10/2013 | SUPPL-4 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 05/20/2013 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 06/10/2026 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022434s014lbl.pdf | |
| 12/06/2019 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022434s013lbl.pdf | |
| 06/18/2018 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022434s011lbl.pdf | |
| 05/26/2016 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022434s010lbl.pdf | |
| 09/09/2014 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022434s006lbl.pdf | |
| 06/29/2011 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022434s000lbl.pdf |